Literature DB >> 10611642

Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3, 4-methylenedioxymethamphetamine (MDMA).

B Horan1, E L Gardner, C R Ashby.   

Abstract

In this study, we measured conditioned place preference (CPP) responses to cocaine following subchronic administration of the recreationally abused drug (+/-)-3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in male Sprague-Dawley rats. Animals were given either vehicle (1 ml/kg of distilled water, s.c.) or MDMA (20 mg/kg, s.c.) twice a day for 4 consecutive days. Two weeks later, CPP responses to cocaine (5, 10, or 20 mg/kg, i.p.) were measured. The MDMA-treated animals showed a significantly greater CPP response to cocaine than the vehicle-treated animals. Since conditioned place preference is believed to be a measure of appetitive behavior, these results suggest that MDMA abuse could lead to an increased vulnerability to the rewarding actions of cocaine and, hence, to increased vulnerability to cocaine addiction and dependence. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10611642     DOI: 10.1002/(SICI)1098-2396(200002)35:2<160::AID-SYN9>3.0.CO;2-O

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  14 in total

1.  Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse.

Authors:  J C Cole; H R Sumnall; E O'Shea; C A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2003-02-25       Impact factor: 4.530

2.  The selective dopamine D3 receptor antagonist SB-277011A reduces nicotine-enhanced brain reward and nicotine-paired environmental cue functions.

Authors:  Arlene C Pak; Charles R Ashby; Christian A Heidbreder; Maria Pilla; Jeremy Gilbert; Zheng-Xiong Xi; Eliot L Gardner
Journal:  Int J Neuropsychopharmacol       Date:  2006-08-31       Impact factor: 5.176

3.  Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats.

Authors:  Maria Aberg; Dean Wade; Erin Wall; Sari Izenwasser
Journal:  Neurotoxicol Teratol       Date:  2006-09-14       Impact factor: 3.763

4.  An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague-Dawley rats.

Authors:  John J Panos; Lisa E Baker
Journal:  Psychopharmacology (Berl)       Date:  2010-01-30       Impact factor: 4.530

5.  Influence of abstinence and intervals between extinction trials on the expression of cocaine-conditioned place preference in adolescent rats.

Authors:  Tatyana Poltyrev; Rami Yaka
Journal:  Psychopharmacology (Berl)       Date:  2012-05-03       Impact factor: 4.530

6.  Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.

Authors:  Martha A Cohen; Matthew R Skelton; Tori L Schaefer; Gary A Gudelsky; Charles V Vorhees; Michael T Williams
Journal:  Synapse       Date:  2005-09-01       Impact factor: 2.562

Review 7.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

8.  Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats.

Authors:  Susan Schenk; David Gittings; Malcolm Johnstone; Evangeline Daniela
Journal:  Psychopharmacology (Berl)       Date:  2003-05-28       Impact factor: 4.530

9.  The effects of concurrent administration of +/-3,4-methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat.

Authors:  Anna J Diller; Angelica Rocha; Aaron L Cardon; Rodrigo Valles; Paul J Wellman; Jack R Nation
Journal:  Pharmacol Biochem Behav       Date:  2007-08-08       Impact factor: 3.533

10.  Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats.

Authors:  Megan M W Straiko; Gary A Gudelsky; Lique M Coolen
Journal:  Behav Neurosci       Date:  2007-06       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.